Results Healthcare   |   Results International

Insights

We add value by understanding our sectors inside out, and release regular industry research and reports

Results Healthcare advised Ajinomoto Bio-Pharma Services on the licencing of its Crystalomics Formulation Technology to Kyowa Kirin

By Jason Foss 18 Mar 2021

Ajinomoto Bio-Pharma Services has licensed patents to Crystalomics to Kyowa Kirin

Results Healthcare is delighted to have acted as exclusive advisor to Ajinomoto Bio-Pharma Services, a fully integrated contract development and manufacturing organisation, on the licencing of the patents and know-how to its Crystalomics Formulation Technology, to Kyowa Kirin, a Japan-based global specialty pharmaceutical company.

Crystalomics is a crystallization and complexation technology that enables significant formulation enhancements for large molecule therapeutics.

This is Results Healthcare’s first licensing transaction in the pharmaceutical industry and is a testament to the team’s strong relationships in the sector and its growing capabilities in licensing transactions.

 

Our credentials in Life Sciences

 

Jason Foss

Managing Director

Contact Jason

Insights

Regular Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office